@article{c0a3dd3c28cb450fa1307d908dbff218,
title = "Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9) Reply",
abstract = "N/A",
keywords = "Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Humans, Laser Coagulation, Retinopathy of Prematurity, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Humans, Laser Coagulation, Retinopathy of Prematurity",
author = "Domenico Lepore",
year = "2015",
doi = "10.1016/j.ophtha.2015.02.018",
language = "English",
volume = "122",
pages = "e49--e50",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "-ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710 -Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL: orders@lww.com, INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320",
}